Methylnatrexone
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Methylnatrexone, covering 2025-12-17 to 2025-12-17. Get the full timeline:
Most recent: Clinical Trial Update: Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study. [Phase 4]